“Drug Price Management Office of the NHIS is in charge of practical work to apply the results of research services for full-cycle management of pharmaceuticals to the field. It reviews and tries to realize the improvement or reform of the system related to pharmaceuticals. "

Kang Cheong-hee, the executive director of the NHIS’ benefit related dept., commented on the direction of the drug price management office, which was newly established on January 1 of this year, at a briefing at the Professional Reporters Council on the 23rd.

The need for full-cycle management of medicines has emerged as social issues such as the supply shutdown of Lipiodol in 2018, the impurities of Valsartan in 20